thiazoles has been researched along with Vitreoretinopathy, Proliferative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grisanti, S; Lüke, J; Lüke, M; Nassar, K; Soliman, M; Tura, A | 1 |
| de Castro, JP; Kaplan, HJ; Liu, L; McDonald, K; Scott, PA; Tamiya, S; Umazume, K | 1 |
2 other study(ies) available for thiazoles and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
A TGF-β receptor 1 inhibitor for prevention of proliferative vitreoretinopathy.
Topics: Animals; Cell Proliferation; Cell Transdifferentiation; Disease Models, Animal; Fibroblasts; Humans; Intravitreal Injections; Protein Serine-Threonine Kinases; Pyrazoles; Pyrroles; Rabbits; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Retinal Pigment Epithelium; Tenon Capsule; Tetrazolium Salts; Thiazoles; Vitreoretinopathy, Proliferative | 2014 |
Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine.
Topics: Animals; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Dasatinib; Disease Models, Animal; Electroretinography; Female; Fetus; Pregnancy; Protein Kinase Inhibitors; Pyrimidines; Retinal Detachment; Retinal Pigment Epithelium; Swine; Thiazoles; Vitreoretinopathy, Proliferative; Vitreous Body | 2013 |